IHS Chemical Week

Regions :: North America

Cambrex reports sales jump on branded APIs

1:06 PM MDT | November 1, 2013 | Lindsay Frost

Cambrex today reported its third quarter results—with net income falling 8.6% year-over-year (YOY), to $17 million. The company reported income from continuing operations of 20 cts/share compared with 7 cts/share in the year-ago quarter. This is slightly below analyst estimates of 21 cts/share, according to Thomson Reuters (New York). Sales of $78 million were up 30% YOY and include a favorable foreign exchange benefit. Sales increased primarily due to higher sales of a large phase-3 product and certain branded active pharmaceutical ingredients (APIs)...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa